Longeveron, Inc. (LGVN)
1.16
+0.06
(+5.45%)
USD |
NASDAQ |
Apr 07, 16:00
1.16
0.00 (0.00%)
After-Hours: 20:00
Longeveron Shareholders Equity (Quarterly) : 5.675M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Acadia Healthcare Co., Inc. | 1.949B |
| Charles River Laboratories International, Inc. | 3.165B |
| BioRestorative Therapies, Inc. | 0.3567M |
| Fate Therapeutics, Inc. | 207.18M |
| CytomX Therapeutics, Inc. | 99.01M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.26M |
| Total Liabilities (Quarterly) | 4.586M |
| Debt to Equity Ratio | 0.1452 |
| Current Ratio | 1.334 |
| Net Debt Paydown Yield | 1.34% |